Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

NYC Targets Cooling Systems Linked to Legionnaires’ Outbreak

By Drug Discovery Trends Editor | August 5, 2015

New York City Mayor Bill de Blasio holds up a chart documenting the cases of Legionnaires' disease while speaking to reporters at Lincoln Hospital in the Bronx borough of New York, Tuesday, Aug. 4, 2015. The death toll from an outbreak of Legionnaires' disease has risen from four to seven people, city health officials announced Monday at a public town hall meeting of concerned residents. (AP Photo/Seth Wenig)Lawmakers are rushing to draft New York’s first regulations for a type of heavy-duty rooftop air conditioning equipment amid suspicions that bacteria-laden mist from these units could be the cause of the deadliest known outbreak of Legionnaires’ disease in the city’s history.
 
Seven people have died and at least 86 have fallen ill in the South Bronx since July 10. People can get exposed to Legionella bacteria from a variety of sources, but cooling towers have been implicated in past outbreaks. Testing found five contaminated units in the part of the city where people are getting sick.
 
Five things to know about the outbreak:
 
—
 
HOW COMMON IS LEGIONNAIRES’ DISEASE?
 
Between 8,000 and 18,000 people are hospitalized in the U.S. each year with Legionnaires’ disease, which is a type of pneumonia, according to the Centers for Disease Control and Prevention. The number of cases reported to the CDC each year has been rising, roughly doubling between 2000 and 2009.
 
A study in New York City found 1,449 cases and 185 deaths between 2002 and 2011. That’s an average of around 19 deaths per year.
 
“Let’s be clear that Legionnaires’ disease has been a persistent health problem for years. A problem all over the country. A problem that has been slowing and steadily growing all over the country,” Mayor Bill de Blasio said Tuesday.
 
—
 
WHERE IT LURKS
 
The bacteria can thrive in warm water and become especially dangerous when the water is turned into a mist that can be inhaled.
 
Medical investigators have linked past outbreaks to public fountains, air conditioning systems, spas, showers and even the misters than keep fruit moist in supermarkets. In the case of New York City’s outbreak, the infected people might have simply been walking by on the street when they inhaled the mist.
 
Investigators are still trying to determine which, if any, of the five cooling towers are directly linked to the illnesses. The presence of the bacteria doesn’t necessarily mean the equipment infected anyone.
 
The disease is not transmitted person to person, nor can it be transmitted through drinking water.
 
—
 
WHAT IS BEING DONE?
 
The five cooling towers have all been decontaminated, and lawmakers are hurriedly crafting legislation they say could help prevent another such outbreak.
 
Building owners would be required to register the location of cooling towers with the city. There will also be a schedule of mandatory inspections, plus rules mandating a prompt disinfection if bacteria are found.
 
This type of regulation is rare in the U.S. but has existed for years in some other countries. Quebec, Canada, instituted similar rules after a Legionnaires’ disease outbreak in Quebec City in 2012.
 
—
 
HOW BAD IS THIS OUTBREAK?
 
City officials suspect the outbreak is starting to ease. They believe it peaked on July 30, and they have seen a decline in new cases since then. The first contaminated cooling tower was discovered and cleaned on July 29.
 
Health Commissioner Dr. Mary Bassett called it “the largest outbreak of Legionnaire’s disease that we are aware of in New York City.”
 
It hasn’t been nearly as bad as the episode that gave the illness its name – the 1976 outbreak that killed 34 people who had attended an American Legion convention in Philadelphia.
 
Legionnaires’ disease is treatable with standard antibiotics and has a fatality rate of between 5 and 10 percent.
 
—
 
WHO IS AT RISK?
 
Researchers say one reason for the increase in reported cases is that there are more elderly and chronically ill people than in decades past. Those people are more susceptible to the illness.
 
City health officials said the victims of this outbreak all had other serious health problems.
 
Source: Associated Press


Filed Under: Drug Discovery

 

Related Articles Read More >

TransCelerate CEO Janice Chang wants trials to become part of routine care
STEERLife’s FragMelt platform manufactures drugs with heat sensitive active ingredient 
S&P report highlights Big Pharma’s concentration risk amid pre-JPM deal flurry
Eli Lilly in the Drug Discovery & Development Pharma 50
Lilly Phase 3b trial shows roughly 40-fold higher combined arthritis and weight-loss response
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2026 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE